These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 6433363

  • 1. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
    Hesse B, Lankisch PG, Kunze H.
    Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
    Schädlich HR, Büchler M, Beger HG.
    Klin Wochenschr; 1989 Feb 01; 67(3):160-2. PubMed ID: 2494376
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
    Freise J, Magerstedt P, Schmid K.
    Enzyme; 1983 Feb 01; 30(3):209-12. PubMed ID: 6194983
    [Abstract] [Full Text] [Related]

  • 4. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
    Freise J, Wittenberg H, Magerstedt P.
    Klin Wochenschr; 1989 Feb 01; 67(3):149-52. PubMed ID: 2467043
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
    Nishijima J, Okamoto M, Nakaguchi K, Ogawa M, Yamano T, Mori T.
    Gen Pharmacol; 1985 Feb 01; 16(3):177-82. PubMed ID: 3926598
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of the anti-inflammatory serine esterase inhibitor, FOY, on phospholipase A2 (EC 3.1.1.4) activity in rabbit polymorphonuclear leukocytes.
    Kunze H, Bohn E, Damerau B.
    Pharmacol Res Commun; 1983 Oct 01; 15(9):869-78. PubMed ID: 6417683
    [Abstract] [Full Text] [Related]

  • 11. [Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept].
    Kahle M, Klein U, König W, Martin U, Alles JU.
    Z Gastroenterol; 1985 Dec 01; 23(12):687-93. PubMed ID: 3937346
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
    Stöckmann F, Göke B, Otto J, Lankisch PG, Creutzfeldt W.
    Z Gastroenterol; 1984 Jun 01; 22(6):311-7. PubMed ID: 6205521
    [Abstract] [Full Text] [Related]

  • 14. Are phospholipid-binding proteins in vivo phospholipase inhibitors?
    Poensgen J.
    Klin Wochenschr; 1989 Feb 01; 67(3):163-5. PubMed ID: 2494377
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis.
    Chen HM, Shyr MH, Chen MF.
    J Formos Med Assoc; 1997 Sep 01; 96(9):704-9. PubMed ID: 9308324
    [Abstract] [Full Text] [Related]

  • 18. The effect of gabexate mesilate on the outcome of acute hemorrhagic pancreatitis in pigs.
    Ristkari SK, Rämö OJ, Kiviniemi H, Gröhn P, Mahlberg K, Mokka RE.
    Res Exp Med (Berl); 1989 Sep 01; 189(1):1-8. PubMed ID: 2496446
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gabexate mesilate (FOY) inhibition of amylase and phospholipase A(2) activity in sow pancreatic juice.
    Caronna R, Loretta D, Campedelli P, Catinelli S, Nofroni I, Sibio S, Sinibaldi G, Chirletti P.
    J Invest Surg; 2003 Sep 01; 16(6):345-51. PubMed ID: 14708545
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.